MedPath

A Prospective Observational Study on the Efficacy of detecting circulating tumor DNA by Means of a Next-Generation Sequencer Using Cell-Free DNA in lung cancer patients

Not Applicable
Conditions
on-small cell lung cancer
Registration Number
JPRN-UMIN000041237
Lead Sponsor
Chiba University Graduate School of Medicine
Brief Summary

15 patients were enrolled in this study. We are observing their postoperative course. We have begun analyzing specimens mainly from recurrent cases.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1. Positive for infection (HBs antigen, HCV antibody, HIV antibody, HTLV-1 antibody) 2. Cases in which the principal investigator determined that the subject was inappropriate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath